Suchergebnisse - "Sanne, Ian"

PubPharm (24)

1

Effect of seven anti-tuberculosis treatment regimens on sputum microbiome : a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials

enthalten in: The Lancet. Microbe | 2023

von Musisi, E. | Wyness, A. | Eldirdiri, S. | +74

2

Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349)

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Pettit, A. | Phillips, P. | Kurbatova, E. | +20

3

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis

enthalten in: The New England journal of medicine | 2021

von Dorman, S. | Nahid, P. | Kurbatova, E. | +130

CommentIn: N Engl J Med. 2021 May 6;384(18):1764-1765. - PMID 33951367

4

Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von Podany, A. | Leon-Cruz, J. | Hakim, J. | +43

5

TB sequel : incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB - a study protocol

enthalten in: BMC pulmonary medicine | 2019

von Rachow, A. | Ivanova, O. | Wallis, R. | +14

6

High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa

enthalten in: PloS one | 2018

von Hirasen, K. | Berhanu, R. | Evans, D. | +3

7

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis : a multi-arm, multi-stage randomised controlled trial

enthalten in: The Lancet. Infectious diseases | 2017

von Boeree, M. | Heinrich, N. | Aarnoutse, R. | +27

CommentIn: Lancet Infect Dis. 2017 Jan;17 (1):2-3. - PMID 28100437

8

Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa : An Observational Cohort Study

enthalten in: PloS one | 2016

von Berhanu, R. | Schnippel, K. | Mohr, E. | +4

9

Host-Directed Therapies for Tackling Multi-Drug Resistant Tuberculosis : Learning From the Pasteur-Bechamp Debates

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2015

von Zumla, A. | Maeurer, M. | Host-Directed Therapies Network (HDT-NET) Consortium | +64

10

Towards host-directed therapies for tuberculosis

enthalten in: Nature reviews. Drug discovery | 2015

von Zumla, A. | Maeurer, M. | Host-Directed Therapies Network | +63